引用本文:
【打印本页】   【下载PDF全文】   View/Add Comment  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 4584次   下载 3598 本文二维码信息
码上扫一扫!
分享到: 微信 更多
生物制剂治疗类风湿关节炎的研究进展
石宇红(综述),谭 毅(审校)
541002 广西,桂林医学院附属医院风湿免疫科
摘要:
[摘要] 类风湿关节炎(RA)是一类常见致残性自身免疫性疾病,传统的治疗药物主要有非甾体抗炎药、糖皮质激素等,但仍有部分病人病情无法控制,最终导致关节进行性破坏。近年来,多种生物制剂的出现为难治性RA的治疗带来了希望,可以有效控制风湿病活动和改善患者生活质量。该文就生物制剂在RA中的治疗进展作一综述。
关键词:  类风湿关节炎  生物制剂  治疗
DOI:10.3969/j.issn.1674-3806.2012.06.33
分类号:R 593.22
基金项目:广西卫生厅科研课题(编号:Z2009044)
Progress of biological agents for treatment of rheumatoid arthritis
SHI Yu-hong,TAN Yi
Department of Rheumatology,the Affiliated Hospital of Guilin Medical University,Guangxi 541002,China
Abstract:
[Abstract] Rheumatoid arthritis(RA) is a common disabling autoimmune diseases.Traditional drugs treatment for RA include nonsteroid anti-inflammatory drugs,corticosteroids and so on.Lots of patients can′t get satisfied control for the condition of refractory RA,and result in severe joint damage.Biological agents have revolutionized the treatment of RA.These agents play an important role in the control of rheumatic conditions and the improvement of quality of life in RA patients.
Key words:  Department of Rheumatology,the Affiliated Hospital of Guilin Medical University,Guangxi 541002,China